Letters to the Editor Open access

Treatment with perilesional injections of pentoxifylline in patients with Peyronie's disease improves the therapeutic effect of oral and topical antioxidant therapy

Authors

Published
11 February 2025
Section
Letters to the Editor

Abstract

To the Editor,

We conducted a retrospective study to demonstrate that it is possible to achieve better therapeutic outcomes through combining perilesional injections of pentoxifylline (PTX) with oral antioxidants and the local application of a cream containing antioxidants and a gel containing diclofenac in patients with Peyronie's disease (PD)...

References

  1. Pryor JP, Ralph DJ. Clinical presentations of Peyronie’s disease. Int. J Impot Res. 2002; 14:414–417. DOI: https://doi.org/10.1038/sj.ijir.3900877
  2. Garaffa G, Trost LW, Serefoglu EC, et al. Understanding the course of Peyronie's disease. Int J Clin Pract. 2013; 67:781–788. DOI: https://doi.org/10.1111/ijcp.12129
  3. Brant WO, Dean RC, Lue TF. Treatment of Peyronie's disease with oral pentoxifylline. Nat Clin Pract Urol. 2006; 3:111-115. DOI: https://doi.org/10.1038/ncpuro0409
  4. Smith JF, Shindel AW, Huang YC, et al. Pentoxifylline treatment and penile calcifications in men with Peyronie’s disease. Asian J Androl. 2011; 13:322–325. DOI: https://doi.org/10.1038/aja.2010.117
  5. Ibrahim A, Gazzard L, Alharbi M, et al. Evaluation of Oral Pentoxifylline, Colchicine, and Penile Traction for the Management of Peyronie's Disease. Sex Med. 2019; 7:459–463. DOI: https://doi.org/10.1016/j.esxm.2019.07.003
  6. Paulis G, Barletta D, Turchi P, et al. Efficacy and safety evaluation of pentoxifylline associated with other antioxidants in medical treatment of Peyronie’s disease: A case-control study. Res Rep Urol. 2016; 8:1-10. DOI: https://doi.org/10.2147/RRU.S97194

Metrics

Citations and online attention from Dimensions, Altmetric and PlumX.